Shandong Weigao Group Medical Polymer Co Ltd
XMUN:UK2

Watchlist Manager
Shandong Weigao Group Medical Polymer Co Ltd Logo
Shandong Weigao Group Medical Polymer Co Ltd
XMUN:UK2
Watchlist
Price: 0.3848 EUR Market Closed
Market Cap: €4.6B

Wall St Price Targets

UK2 Price Targets Summary
Shandong Weigao Group Medical Polymer Co Ltd

Wall Street analysts forecast UK2 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UK2 is 0.7106 EUR with a low forecast of 0.4593 EUR and a high forecast of 0.936 EUR.

Lowest Forecast
Price Target
0.4593 EUR
19% Upside
Average Forecast
Price Target
0.7106 EUR
85% Upside
Highest Forecast
Price Target
0.936 EUR
143% Upside
Shandong Weigao Group Medical Polymer Co Ltd Competitors:
Price Targets
1INN
innoscripta SE
172% Upside
VRTX
Vertex Pharmaceuticals Inc
26% Upside

Revenue
Forecast

11% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
11% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.

Gross Profit
Forecast

10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Shandong Weigao Group Medical Polymer Co Ltd

Operating Income
Forecast

6% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
6% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is 22%.

Pre-Tax Income
Forecast

-4% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-4% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Shandong Weigao Group Medical Polymer Co Ltd

Net Income
Forecast

-6% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
-6% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been -6%. The projected CAGR for the next 3 years is 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is UK2's stock price target?
Price Target
0.7106 EUR

According to Wall Street analysts, the average 1-year price target for UK2 is 0.7106 EUR with a low forecast of 0.4593 EUR and a high forecast of 0.936 EUR.

What is the Revenue forecast for Shandong Weigao Group Medical Polymer Co Ltd?
Projected CAGR
6%

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 6%.

What is the Operating Income forecast for Shandong Weigao Group Medical Polymer Co Ltd?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is 22%.

What is the Net Income forecast for Shandong Weigao Group Medical Polymer Co Ltd?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Net Income has been -6%. The projected CAGR for the next 3 years is 7%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett